Table 1 Baseline characteristics of 440 female sex workers followed-up in a microbicide trial at 2 african and 2 indian sites
Characteristics | n with (%) or median with [IQR*] |
|---|---|
Sites: | |
Kampala | 167 (37.9) |
Cotonou | 140 (31.8) |
Indian sites (Chennai and Bagalkot District) | 133 (30.2) |
Age in years | 28 [23-35] |
Completed years of school | 7 [3-9] |
Cohabiting with a man | 94 (21.4) |
Exerting an occupation other than commercial sex work | 128 (29.1) |
Currently used contraceptive: | |
None | 255 (57.9) |
Oral | 29 (6.6) |
Injectable | 35 (7.9) |
Intra-uterine device | 3 (0.7) |
Female sterilization | 118 (26.8) |
Having a primary partner | 331 (75.2) |
Number of sexual partners in the past 7 days† | 8 [4 – 21] |
Percentage of sexual act with primary partner using condom 100% ‡ | 97 (46.6) |
Percentage of sexual act with other partners using condom 100% ¶ | 361 (97.6) |
Oral or anal sex in the past 30 days with primary partner © | 15 (5.8) |
Oral or anal sex in the past 30 days with primary partner without condom © | 10 (4.2) |
Oral or anal sex in the past 30 days with other partners # | 22 (5.0) |
Oral or anal sex in the past 30 days with other partners without condom # | 8 (1.4) |
History of STI at baseline | 321 (72.9) |
Recent intra-vaginal cleansing (within 90 days) @ | 73 (17.6) |
Irregular menstrual cycles | 97 (22.0) |
Laboratory diagnosis of STI or reproductive tract infections at baseline: | |
Gonorrhoea § | 27 (6.2) |
Chlamydia § | 28 (6.4) |
Trichomoniasis ¥ | 20 (4.6) |
Candidiasis ¥ | 112 (25.6) |